Atlas Engineered Products Ltd. (TSXV:AEP)

Elevation Oncology Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	57	94	67	43	35	24
Market Cap Growth	-24.89%	39.09%	55.46%	25.26%	46.34%	28.03%
Enterprise Value	72	102	92	46	39	31
Last Close Price	0.81	1.33	1.14	0.75	0.60	0.41
PE Ratio	-	-	21.41	4.91	4.98	103.36
PS Ratio	0.99	1.68	1.37	0.70	0.63	0.66
PB Ratio	1.19	1.93	1.96	1.50	1.75	1.83
P/TBV Ratio	2.70	4.37	9.40	2.47	2.86	5.17
P/FCF Ratio	-	-	17.48	5.67	4.20	105.28
P/OCF Ratio	95.36	37.83	15.04	3.84	3.62	41.69
EV/Sales Ratio	1.24	1.82	1.86	0.75	0.71	0.87
EV/EBITDA Ratio	8.77	14.83	11.79	3.17	3.40	14.85
EV/EBIT Ratio	24.36	35.08	17.44	3.68	3.96	64.91
EV/FCF Ratio	-13.95	-	23.81	6.03	4.73	138.94
Debt / Equity Ratio	0.49	0.51	1.11	0.53	0.47	0.71
Debt / EBITDA Ratio	2.87	3.05	4.35	0.99	0.75	2.83
Debt / FCF Ratio	-	-	9.92	1.99	1.14	41.04
Asset Turnover	0.77	0.70	0.76	1.44	1.75	1.33
Inventory Turnover	4.83	5.66	6.29	10.56	13.81	13.83
Quick Ratio	2.25	2.87	3.00	3.23	2.31	1.40
Current Ratio	3.62	3.96	3.89	3.92	2.85	1.85
Return on Equity (ROE)	-0.16%	-0.51%	9.95%	36.27%	42.48%	2.17%
Return on Assets (ROA)	2.45%	2.26%	5.07%	18.15%	19.65%	1.12%
Return on Capital (ROIC)	2.71%	2.48%	5.63%	21.36%	24.05%	1.38%
Return on Capital Employed (ROCE)	4.20%	4.00%	7.40%	28.70%	34.10%	2.20%
Earnings Yield	-0.11%	-0.23%	4.67%	20.35%	20.08%	0.97%
FCF Yield	-9.04%	-1.97%	5.72%	17.63%	23.84%	0.95%
Buyback Yield / Dilution	-10.73%	-11.54%	3.32%	18.10%	-1.82%	-64.96%

Updated Nov 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.